GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » Change In Payables And Accrued Expense

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Change In Payables And Accrued Expense : ₫0.00 Mil (TTM As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company Change In Payables And Accrued Expense?

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Change In Payables And Accrued Expense for the quarter that ended in . 20 was ₫0.00 Mil. It means Pharmedic Pharmaceutical Medicinal Joint Stock Company's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was ₫0.00 Mil. It means Pharmedic Pharmaceutical Medicinal Joint Stock Company's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .


Pharmedic Pharmaceutical Medicinal Joint Stock Company Change In Payables And Accrued Expense Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Change In Payables And Accrued Expense Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
Change In Payables And Accrued Expense

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
Change In Payables And Accrued Expense

Pharmedic Pharmaceutical Medicinal Joint Stock Company Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmedic Pharmaceutical Medicinal Joint Stock Company Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Traded in Other Exchanges
N/A
Address
367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010